{"SPADE_UN_17515": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17515", "Peptide Name": "", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "KWWKLLRKKR", "Sequence Length": 10, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C70H116N22O11", "Mass": 1441.81, "PI": 12.0, "Net Charge": 6, "Hydrophobicity": -1.88, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)", "Pubmed ID": "33074344", "Reference": "Amino Acids. 2020 Oct;52(10)1439-1458.", "Author": "Faya M, Hazzah HA, Omolo CA, Agrawal N, Maji R, Walvekar P, Mocktar C, Nkambule B, Rambharose S, Albericio F, de la Torre BG, Govender T.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33074344"}], "Frequent Amino Acids": "KLR", "Absent Amino Acids": "ACDEFGHIMNOPQSTUVY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 4, "Polar Residues": 6, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_11043", "Similarity": 1.0, "Sequence": "VKRWKKFWRKWKKWW"}, {"SPADE_ID": "SPADE_N_11084", "Similarity": 1.0, "Sequence": "IKKILSKIKKWWK"}, {"SPADE_ID": "SPADE_N_11085", "Similarity": 1.0, "Sequence": "IKKIWSKIKKWWK"}]}}}